Kao S T, Lin C S, Hsieh C C, Hsieh W T, Lin J G
Institute of Chinese Medical Science, China Medical College, No. 91 Hsueh Shih Road, Taichung, Taiwan, ROC.
Allergy. 2001 Dec;56(12):1164-71. doi: 10.1034/j.1398-9995.2001.00982.x.
Xiao-qing-long-tang (XQLT sho-seiru-to), a traditional Chinese medicine, has been used to treat patients with bronchial asthma in Oriental countries for several centuries. However, the therapeutic mechanisms of this Chinese medicine remain a matter of considerable debate. Therefore, a series of experiments using ovalbumin-sensitized guinea pigs was performed to elucidate the possible antiasthmatic effect of XQLT.
The effect of XQLT on ovalbumin-induced airway inflammation in a guinea pig model of allergic asthma was examined, and early and late asthmatic responses were measured in terms of airway resistance and extent of eosinophil infiltration. Furthermore, the bronchorelaxing effect of XQLT was measured in isolated guinea pig trachea.
XQLT significantly inhibited the antigen-induced immediate asthmatic response (IAR) and late asthmatic response (LAR) in actively sensitized guinea pigs. Cumulative administration of XQLT caused concentration-dependent relaxation of the carbachol-precontracted guinea pig trachea. The bronchorelaxing effect of XQLT was reversed by ICI-118551, a selective beta2-adrenoceptor antagonist. Furthermore, examination of bronchoalveolar lavage fluid (BALF) revealed that XQLT significantly suppressed the increase in eosinophils (24 h after antigen challenge) in the airway. In addition, XQLT significantly attenuated the increase in eosinophils at 1, 6, 24, 48, and 72 h after antigen challenge when it was administered once daily from the day of sensitization to the day of challenge. Histopathologic examination results showed that XQLT suppressed eosinophil infiltration into lung tissue.
These results demonstrate that the antiasthmatic effects of XQLT appear to be partly mediated by stimulation of beta2-adrenoceptors, leading to bronchorelaxation, and that XQLT inhibits the infiltration of eosinophils into the airway. Thus, XQLT may be useful for the prevention or treatment of asthma.
中药小青龙汤在东方国家已用于治疗支气管哮喘患者数百年。然而,这种中药的治疗机制仍存在相当大的争议。因此,进行了一系列使用卵清蛋白致敏豚鼠的实验,以阐明小青龙汤可能的抗哮喘作用。
研究了小青龙汤对变应性哮喘豚鼠模型中卵清蛋白诱导的气道炎症的影响,并从气道阻力和嗜酸性粒细胞浸润程度方面测量了早期和晚期哮喘反应。此外,在离体豚鼠气管中测量了小青龙汤的支气管舒张作用。
小青龙汤显著抑制了主动致敏豚鼠的抗原诱导的速发型哮喘反应(IAR)和迟发型哮喘反应(LAR)。小青龙汤的累积给药导致卡巴胆碱预收缩的豚鼠气管出现浓度依赖性舒张。小青龙汤的支气管舒张作用被选择性β2肾上腺素能受体拮抗剂ICI-118551逆转。此外,支气管肺泡灌洗液(BALF)检查显示,小青龙汤显著抑制了气道中嗜酸性粒细胞的增加(抗原激发后24小时)。此外,从致敏当天至激发当天每天给药一次时,小青龙汤在抗原激发后1、6、24、48和72小时显著减轻了嗜酸性粒细胞的增加。组织病理学检查结果显示,小青龙汤抑制了嗜酸性粒细胞向肺组织的浸润。
这些结果表明,小青龙汤的抗哮喘作用似乎部分是通过刺激β2肾上腺素能受体导致支气管舒张介导的,并且小青龙汤抑制嗜酸性粒细胞向气道的浸润。因此,小青龙汤可能对哮喘的预防或治疗有用。